Richardson Financial Services Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Richardson Financial Services Inc.
- $149 Billion
- Q2 2025
A detailed history of Richardson Financial Services Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Richardson Financial Services Inc. holds 525 shares of CPRX stock, worth $11,009. This represents 0.01% of its overall portfolio holdings.
Number of Shares
525
Previous 434
20.97%
Holding current value
$11,009
Previous $10.5 Million
5.7%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CPRX
# of Institutions
383Shares Held
99.5MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$116 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$71.8 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$65.8 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.16B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...